Dr Amos L Lash Sr, MD | |
1304 E 32nd St, Silver City, NM 88061-7252 | |
(575) 534-0556 | |
(575) 534-9107 |
Full Name | Dr Amos L Lash Sr |
---|---|
Gender | Male |
Speciality | Urology |
Location | 1304 E 32nd St, Silver City, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639133788 | NPI | - | NPPES |
MD2009-0006 | Other | NM | NEW MEXICO PHYSICIANS LICENSE |
G34981 | Other | CA | PHY SURG LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | G34981 (California) | Secondary |
208800000X | Urology | MD2009-0006 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Amos L Lash Sr, MD 1304 E 32nd St, Silver City, NM 88061-7252 Ph: (575) 534-0556 | Dr Amos L Lash Sr, MD 1304 E 32nd St, Silver City, NM 88061-7252 Ph: (575) 534-0556 |
News Archive
New England Biolabs, Inc. announces the issuance of United States Patent Number 8,999,677, which describes a novel method for retaining valuable strand-specific information contained within RNA transcripts.
It's known that racial minorities in the United States undergo fewer total knee replacements (TKRs) for knee osteoarthritis, but it's unclear how this affects their quality of life.
OptiMedica Corp., a global ophthalmic device company, has released new details regarding the development of its proprietary femtosecond laser system for cataract surgery. The new system, which combines OptiMedica's breakthrough pattern scanning technology, an ultra-fast laser and integrated Optical Coherence Tomography imaging, is designed to dramatically improve the complex cataract procedure by replacing its most technically demanding and manual steps.
Detecting hidden genetic defects by applying an existing method to an existing datasets. Researchers at Radboud university medical center have succeeded.
Northeast Ohio Medical University researcher and professor of anatomy and neurobiology Jianxin Bao, Ph.D., has received a large federal grant to produce the first human treatment for tinnitus, a disruptive hearing impairment marked by the perception of ringing or buzzing in one or both ears.
› Verified 6 days ago
Dr. Mark Ira Leibowitz, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1264 E 32nd St, Silver City, NM 88061 Phone: 505-534-1444 Fax: 505-534-1449 |